Journals / Diagnostic and Interventional Radiology / 2022 / Cilt: 28 - Sayı: 1

Fat- and iron-corrected ADC to assess liver fibrosis in patients with chronic hepatitis B

Pages
5–11
Publication Date
2022-10-11
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

The ADC corrected for the effects of steatosis may be more reliable for identifying liver fibrosis.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:PURPOSE We aimed to evaluate the diagnostic performance of apparent diffusion coefficient (ADC) in assessing liver fibrosis after correcting for the effects of hepatic steatosis or iron deposition.
📊
Key Findings & Data:Significant fibrosis and cirrhosis were diagnosed with the APRI.
💡
Conclusion & Impact:The ADC corrected for the effects of steatosis may be more reliable for identifying liver fibrosis.
🔬Design:Research Article
📍Scope:Comprehensive Sample
⚙️Variables:Domain Parameters

Abstract

PURPOSE We aimed to evaluate the diagnostic performance of apparent diffusion coefficient (ADC) in assessing liver fibrosis after correcting for the effects of hepatic steatosis or iron deposition. METHODS Seventy-three patients with chronic hepatitis B (CHB) were included in this retrospective study. The aspartate aminotransferase-to-platelet ratio index (APRI) was calculated for classification of the fibrosis grade. Significant fibrosis and cirrhosis were diagnosed with the APRI. The proton density fat fraction (PDFF), R2*, and ADC values were measured. The impact of the PDFF and R2* on the ADC was analyzed. The PDFF- and R2*-corrected ADC values (ADCPDFF and ADCR2*) were calculated according to linear regression equations. The diagnostic performance of uncorrected ADC (ADCu ), ADCPDFF and ADCR2* in predicting significant fibrosis and cirrhosis was assessed, and the area under the curve (AUC) values were compared. RESULTS Among the 73 patients in this study, the mean ADC was 0.866 ± 0.084×10-3 mm2 /s, the mean R2* was 60.24 (42.77, 85.37) 1/s, and the mean PDFF was 2.90% (1.60%- 4.80%). The ADC was negatively correlated with the PDFF (r= -0.298, P = .010) and R2* (r = -0.457, P < .001). Linear regression analysis showed that the PDFF and R2* were independent factors of the ADC (β= -0.315, P = .007, R2 = 0.099 and β= -0.493, P < .001, R2 = 0.243, respectively). Compared with the uncorrected ADC (r= -0.307, P = .022), the correlation between the ADCPDFF and fibrosis grade increased (r= -0.513, P < .001), and the correlation between the ADCR2* and fibrosis grade decreased (r=-0.168, P = .215). The AUC of the ADCPDFF was significantly larger than that of the ADCu in the diagnosis of significant fibrosis and cirrhosis, which increased from 0.68 to 0.81 (P = .003) for predicting significant fibrosis and from 0.75 to 0.84 (P = .009) for predicting cirrhosis. The AUCs for the ADCR2* in the diagnosis of significant fibrosis and cirrhosis were both lower than that for the uncorrected ADC (P = .206 and P = .109, respectively). CONCLUSION After correcting for the effects of steatosis, the diagnostic performance of the ADC for significant fibrosis and cirrhosis increased. The ADC corrected for the effects of steatosis may be more reliable for identifying liver fibrosis.

🔖

Cite This Article

PAN, Z., LI, Z., MENG, F., HU, Y., ZHANG, X., CHEN, Y. (2022). Fat- and iron-corrected ADC to assess liver fibrosis in patients with chronic hepatitis B. Diagnostic and Interventional Radiology, Cilt: 28 - Sayı: 1, 5–11. https://ajindex.com/articles/487228

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (12)

  1. Tapper EB, Lok AS. Use of liver imaging and biopsy in clinical practice. N Engl J Med. 2017
  2. [Crossref] 2. Lemoine M, Shimakawa Y, Nayagam S, et al. The gamma-glutamyl transpeptidase to platelet ratio (GPR) predicts significant liver fibrosis and cirrhosis in patients with chronic HBV infection in West Africa. Gut. 2016
  3. [Crossref] 3. Castera L. Noninvasive methods to assess liver disease in patients with hepatitis B or C. Gastroenterology. 2012
  4. e4. [Crossref] 4. Gao YY, Zheng J, Liang P, et al. Liver fibrosis with two-dimensional US shear-wave elastography in participants with chronic hepatitis B: A prospective multicenter study. Radiology. 2018
  5. [Crossref] 5. World Health Organization. Guidelines for the prevention, care and treatment of persons with chronic Hepatitis B infection. 2015. 6. Feier D, Balassy C, Bastati N, Fragner R, Wrba F, Ba-Ssalamah A. The diagnostic efficacy of quantitative liver MR imaging with diffusion-weighted, SWI, and hepato-specific contrast-enhanced sequences in staging liver fibrosis--a multiparametric approach. Eur Radiol. 2016
  6. [Crossref] 7. Fujimoto K, Tonan T, Azuma S, et al. Evaluation of the mean and entropy of apparent diffusion coefficient values in chronic hepatitis C: correlation with pathologic fibrosis stage and inflammatory activity grade. Radiology. 2011
  7. [Crossref] 8. Leitao HS, Doblas S, Garteiser P, et al. Hepatic Fibrosis, Inflammation, and Steatosis: Influence on the MR Viscoelastic and Diffusion Parameters in Patients with Chronic Liver Disease. Radiology. 2017
  8. [Crossref] 9. Bulow R, Mensel B, Meffert P, Hernando D, Evert M, Kuhn JP. Diffusion-weighted magnetic resonance imaging for staging liver fibrosis is less reliable in the presence of fat and iron. Eur Radiol. 2013
  9. [Crossref] 10. Karlsson M, Ekstedt M, Dahlstrom N, et al. Liver R2* is affected by both iron and fat: A dual biopsy-validated study of chronic liver disease. J Magn Reson Imaging. 2019
  10. [Crossref] 11. Dieckmeyer M, Ruschke S, Eggers H, et al. ADC Quantification of the vertebral bone marrow water component: removing the confounding effect of residual fat. Magn Reson Med. 2017
  11. [Crossref] 12. Ebrahimi B, Saad A, Jiang K, et al. Renal adiposity confounds quantitative assessment of markers of renal diffusion with MRI: a proposed correction method. Invest Radiol. 2017
  12. [Crossref] 13. Jain A, Bhayana S, Vlassc